These popular funds have something for everyone. Let's see what they offer. The post Buy these excellent ASX ETFs for growth ...

Alterity Therapeutics (ATHE) has received binding commitments for a capital raising of A$40M via a two tranche placement of fully paid ordinary ...

Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or the “Company”), a biotechnology company dedicated to developing disease modifying treatments for neurodegenerative diseases, today ...

In the current Australian market landscape, the ASX200 has experienced a slight decline of 0.36% amidst concerns over new tariffs on aluminium and steel imposed by the Trump administration, with ...

The most you can lose on any stock (assuming you don't use leverage) is 100% of your money. But on a lighter note, ...

This business is a great operator. Is it time to buy? The post This ASX 300 stock soared 15% after reporting. Time to buy? appeared first on The Motley Fool Australia.

Another ASX 200 share that could be a great option for a $10,000 investment is ResMed. It is a global leader in the treatment ...

Leading brokers have named Aristocrat Leisure Ltd (ASX: ALL) and these ASX shares as buys this week. Here's why they are ...

Agrimin is conducting a strategic review in regards to options for its Mackay Potash Project in Western Australia.

Pure-play lithium producer Pilbara Minerals is weighing up its downstream investment strategy against the prospect of more ...

Toronto, Ontario-- (Newsfile Corp. - February 10, 2025) - Visit AuMEGA Metals Limited (ASX: AAM) (TSXV: AUM) at Booth #2749 at the Prospectors & Developers Association of Canada’s (PDAC) Convention at ...

Ansell will hike its prices to offset Donald Trump’s sharp tariff moves as it reveals rising geopolitical tensions has forced ...